Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - Seminars in hematology, 2003 - Elsevier
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
[引用][C] Molecular monitoring of chronic myeloid leukemia
T HUGHES, S BRANFORD - Seminars in hematology, 2003 - pascal-francis.inist.fr
Molecular monitoring of chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …
and Francis Bibliographic Databases Simple search Advanced search Search by …
Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - Seminars in hematology, 2003 - pubmed.ncbi.nlm.nih.gov
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
[引用][C] Molecular monitoring of chronic myeloid leukemia
T HUGHES - Semin Hematol., 2003 - cir.nii.ac.jp
Molecular monitoring of chronic myeloid leukemia.
T Hughes, S Branford - Seminars in Hematology, 2003 - europepmc.org
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - 2003 - digital.library.adelaide.edu.au
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - Seminars in Hematology, 2003 - infona.pl
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - Seminars in Hematology, 2003 - research.sahmri.org.au
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
[引用][C] Molecular monitoring of chronic myeloid leukemia
T HUGHES - Semin Hematol., 2003 - cir.nii.ac.jp
Molecular monitoring of chronic myeloid leukemia | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Molecular monitoring of chronic myeloid leukemia
T Hughes, S Branford - Seminars in Hematology, 2003 - infona.pl
The tyrosine kinase inhibitor imatinib mesylate (Gleevec)(formerly STI571) has proven to be
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …
an effective and safe new therapy for patients with chronic myeloid leukemia (CML). It has …